"US reviewing risks of Roche, Novartis, Biogen drugsWed Feb 17, 2010 WASHINGTON, Feb 17 (Reuters) - U.S. health regulators are reviewing potential risks of medicines from Roche Holding AG , Novartis AG and other companies." . . . .